Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-07-10
DOI
10.3389/fimmu.2020.01708
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
- (2020) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis
- (2020) Alexandre Sepriano et al. ANNALS OF THE RHEUMATIC DISEASES
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
- (2020) Clark D Russell et al. LANCET
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- First Case of 2019 Novel Coronavirus in the United States
- (2020) Michelle L. Holshue et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- The Use of Antimalarial Drugs against Viral Infection
- (2020) Sarah D’Alessandro et al. Microorganisms
- Dramatic improvement after tocilizumab of severe COVID ‐19 in a child with sickle cell disease and acute chest syndrome
- (2020) Marie‐Hélène Odièvre et al. AMERICAN JOURNAL OF HEMATOLOGY
- Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
- (2020) J.-M. Michot et al. ANNALS OF ONCOLOGY
- Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID‐19) infected patients
- (2020) Suxin Wan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Functional exhaustion of antiviral lymphocytes in COVID-19 patients
- (2020) Meijuan Zheng et al. Cellular & Molecular Immunology
- Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome
- (2020) Jared Radbel et al. CHEST
- Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province
- (2020) Kui Liu et al. CHINESE MEDICAL JOURNAL
- Down-regulated gene expression spectrum and immune responses changed during the disease progression in COVID-19 patients
- (2020) Yabo Ouyang et al. CLINICAL INFECTIOUS DISEASES
- Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
- (2020) Zhongliang Wang et al. CLINICAL INFECTIOUS DISEASES
- Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China
- (2020) Mingkai Tan et al. IMMUNOLOGY
- Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib
- (2020) Jeffrey Jacobs et al. INFLAMMATORY BOWEL DISEASES
- Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
- (2020) Xiaochen Li et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis
- (2020) Zhenwei Yang et al. JOURNAL OF INFECTION
- Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China
- (2020) Bo XU et al. JOURNAL OF INFECTION
- Tocilizumab treatment in COVID-19: A single center experience
- (2020) Pan Luo et al. JOURNAL OF MEDICAL VIROLOGY
- Kidney disease is associated with in-hospital death of patients with COVID-19
- (2020) Yichun Cheng et al. KIDNEY INTERNATIONAL
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Corticosteroid treatment of patients with coronavirus disease 2019 ( COVID ‐19)
- (2020) Lei Zha et al. MEDICAL JOURNAL OF AUSTRALIA
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence
- (2020) Jeanne Lenzer BMJ-British Medical Journal
- Decoding the enigma of antiviral crisis: Does one target molecule regulate all?
- (2019) Abdullah Mahmud-Al-Rafat et al. CYTOKINE
- Immune Checkpoint Inhibition in Sepsis
- (2019) Richard S. Hotchkiss et al. CRITICAL CARE MEDICINE
- Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab
- (2019) Richard S. Hotchkiss et al. INTENSIVE CARE MEDICINE
- Dihydroartemisinin attenuates lipopolysaccharide‑induced acute lung injury in mice by suppressing NF‑κB signaling in an Nrf2‑dependent manner
- (2019) Xiao‑Ting Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- The Diverse Function of PD-1/PD-L Pathway Beyond Cancer
- (2019) Weiting Qin et al. Frontiers in Immunology
- Dihydroartemisinin ameliorates sepsis-induced hyperpermeability of glomerular endothelium via up-regulation of occludin expression
- (2018) Zuowang Cheng et al. BIOMEDICINE & PHARMACOTHERAPY
- Artesunate Attenuates Pro-Inflammatory Cytokine Release from Macrophages by Inhibiting TLR4-Mediated Autophagic Activation via the TRAF6-Beclin1-PI3KC3 Pathway
- (2018) Mei Kuang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease
- (2018) Zhongfang Wang et al. Nature Communications
- Hemozoin-induced activation of human monocytes toward M2-like phenotype is partially reversed by antimalarial drugs-chloroquine and artemisinin
- (2018) Deepali Bobade et al. MicrobiologyOpen
- Rheumatoid arthritis
- (2018) Josef S. Smolen et al. Nature Reviews Disease Primers
- Plasmodium falciparum Treated with Artemisinin-based Combined Therapy Exhibits Enhanced Mutation, Heightened Cortisol and TNF-α Induction
- (2018) Abel Olusola Idowu et al. International Journal of Medical Sciences
- Dihydroartemisinin derivative DC32 attenuates collagen-induced arthritis in mice by restoring the Treg/Th17 balance and inhibiting synovitis through down-regulation of IL-6
- (2018) Menglin Fan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria
- (2017) Yunting Du et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- NLRP3mutation and cochlear autoinflammation cause syndromic and nonsyndromic hearing loss DFNA34 responsive to anakinra therapy
- (2017) Hiroshi Nakanishi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- IL-10: A Multifunctional Cytokine in Viral Infections
- (2017) José M. Rojas et al. Journal of Immunology Research
- Artemisinin protects mice against burn sepsis through inhibiting NLRP3 inflammasome activation
- (2016) Huibao Long et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
- (2016) Rudragouda Channappanavar et al. Cell Host & Microbe
- Artesunate ameliorates severe acute pancreatitis (SAP) in rats by inhibiting expression of pro-inflammatory cytokines and Toll-like receptor 4
- (2016) Yanyan Cen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells
- (2016) Janne Tynell et al. JOURNAL OF GENERAL VIROLOGY
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- Immune suppressive properties of artemisinin family drugs
- (2016) Lifei Hou et al. PHARMACOLOGY & THERAPEUTICS
- Artesunate Protects Against Sepsis-Induced Lung Injury Via Heme Oxygenase-1 Modulation
- (2015) Tian-hui Cao et al. INFLAMMATION
- First Successful Combination of ECMO with Cytokine Removal Therapy in Cardiogenic Septic Shock: A Case Report
- (2015) Frank Bruenger et al. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
- Anti-Inflammatory and Immunoregulatory Functions of Artemisinin and Its Derivatives
- (2015) Chenchen Shi et al. MEDIATORS OF INFLAMMATION
- Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
- (2015) Allison L. Totura et al. mBio
- Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection
- (2014) Yaseen M. Arabi et al. ANNALS OF INTERNAL MEDICINE
- Mechanism of NLRP3 inflammasome activation
- (2014) Fayyaz S. Sutterwala et al. Annals of the New York Academy of Sciences
- Middle East Respiratory Syndrome Coronavirus: A Case-Control Study of Hospitalized Patients
- (2014) J. A. Al-Tawfiq et al. CLINICAL INFECTIOUS DISEASES
- Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL/lpr mice
- (2014) Xueqin Huang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Pathogenic Influenza Viruses and Coronaviruses Utilize Similar and Contrasting Approaches To Control Interferon-Stimulated Gene Responses
- (2014) V. D. Menachery et al. mBio
- IL-6 in Inflammation, Immunity, and Disease
- (2014) T. Tanaka et al. Cold Spring Harbor Perspectives in Biology
- Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus
- (2013) R. Germi et al. ANTIVIRAL RESEARCH
- Hyperimmune IV Immunoglobulin Treatment of 2009 Influenza A(H1N1): Response
- (2013) Ivan F.N. Hung et al. CHEST
- Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment
- (2013) S. K. P. Lau et al. JOURNAL OF GENERAL VIROLOGY
- Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis
- (2013) Jie Zhou et al. JOURNAL OF INFECTIOUS DISEASES
- P2X7R: A potential key regulator of acute gouty arthritis
- (2013) Jin-Hui Tao et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Artemisinin inhibits lipopolysaccharide-induced interferon-β production in RAW 264.7 cells: Implications on signal transducer and activator of transcription-1 signaling and nitric oxide production
- (2012) Ki Hwan Park et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Into the Eye of the Cytokine Storm
- (2012) J. R. Tisoncik et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung
- (2012) O Dienz et al. Mucosal Immunology
- Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses
- (2011) Li-Fei Hou et al. ARTHRITIS AND RHEUMATISM
- Hydroxychloroquine: From Malaria to Autoimmunity
- (2011) Ilan Ben-Zvi et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
- (2011) Taro Kawai et al. IMMUNITY
- SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-κB pathways in RAW 264.7 macrophages
- (2009) Jun-xia Wang et al. ACTA PHARMACOLOGICA SINICA
- Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-α release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-κB activation
- (2009) Bin Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses
- (2008) J-X Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Artesunate as a Potent Antiviral Agent in a Patient with Late Drug‐Resistant Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation
- (2008) Michael Y. Shapira et al. CLINICAL INFECTIOUS DISEASES
- Cytokine responses in a severe case of glandular fever treated successfully with foscarnet combined with prednisolone and intravenous immunoglobulin
- (2008) Christine Ma et al. JOURNAL OF MEDICAL VIROLOGY
- Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation
- (2007) J-X Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started